The current ADXS market cap is 666.24k. The company's latest EPS is USD 0.0000 and P/E is N/A.
Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 4k | 9k | 0 |
Operating Income | -7.29M | -4.85M | -11.87M | -8.49M | -7.13M |
Net Income | -6.96M | -4.59M | -7.36M | -8.7M | -7.34M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 20.88M | 253k | 3.24M | 250k | 0 |
Operating Income | -17.97M | -26.45M | -18.79M | -19.31M | 0 |
Net Income | -16.61M | -26.47M | -17.86M | -15.38M | 0 |
Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 30.1M | 25.93M | 21M | 12.15M | 6.98M |
Total Liabilities | 1.91M | 2.3M | 11.32M | 11.14M | 13.22M |
Total Equity | 28.2M | 23.63M | 9.68M | 1.01M | -6.24M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 45.26M | 38.53M | 46.78M | 25.93M | 7.77M |
Total Liabilities | 5.73M | 8.35M | 7.89M | 2.3M | 8.87M |
Total Equity | 39.53M | 30.18M | 38.89M | 23.63M | -1.1M |
Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -12.31M | -15.28M | -6.74M | -15.3M | -22.28M |
Investing | -201k | -166k | N/A | N/A | N/A |
Financing | -956k | -956k | 21.2M | 20M | 22M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -36.13M | -21.94M | -15.44M | -15.28M | N/A |
Investing | -1.2M | -748k | -11k | -166k | N/A |
Financing | 24.57M | 15.5M | 31.89M | -956k | N/A |
Market Cap | 666.24k |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.28 |
Price to Book Ratio | -0.61 |
Dividend Yield | - |
Shares Outstanding | 2.78M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0.8%) |
Company Name | Advaxis Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.ayalapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.